1.Diagnostic value of ultrasonic examination in patients with different stages of liver fibrosis.
Yongpeng CHEN ; Lin DAI ; Xiaorong FENG ; Dingli LIU ; Lian ZHANG ; Kangxian LUO
Chinese Journal of Hepatology 2002;10(2):132-134
OBJECTIVETo discuss the diagnostic value of ultrasonic examination in patients with early liver cirrhosis and the relation with different stages of liver fibrosis.
METHODSIn the series, 263 patients with chronic hepatitis B were under taken liver biopsy and ultrasonic examination of type B for determination of liver cirrhosis images, width of the main portal vein and the splenic vein, tumefaction of the spleen. Data were analysed statistically.
RESULTSSixties of 263 patients were diagnosed as early liver cirrhosis. The diagnostic sensitivity, specificity, misdiagnostic rate, missed diagnostic rate, and Jonden's index of ultrasonic examination for early liver cirrhosis were 52.5%, 88.3%, 11.7%, 47.5%, and 0.508, respectively. The width of the main portal vein with liver fibrosis of S1, S2, S3, and S4 were 10.93 mm +/- 1.25 mm, 11.35 mm +/- 1.06 mm,11.29 mm +/- 1.52 mm, and 11.4 8mm +/- 1.25 mm, respectively with statistic difference between S4 and S1 (P=0.03). The width of the spleen vein of S1, S2, S3, and S4 were 6.518 mm +/- 2.033 mm, 7.190 mm +/- 1.569 mm, 7.444 mm +/- 1.805 mm and 8.406 mm +/- 2.227 mm, respectively with statistic difference between S4 and S2 (P=0.035). The incidence of tumefaction of the spleen was increased with the degree of liver fibrosis.
CONCLUSIONSThe diagnostic sensitivity of ultrasonic examination for early liver cirrhosis is low. The width of the main portal vein, the spleen vein and the incidence of tumefaction of the spleen are related with the degree of liver fibrosis. The regeneration node of liver cirrhosis may contribute to the development of portal hypertension.
Adolescent ; Adult ; Child ; Female ; Hepatitis B, Chronic ; complications ; Humans ; Liver Cirrhosis ; complications ; diagnostic imaging ; pathology ; Male ; Portal Vein ; diagnostic imaging ; pathology ; Sensitivity and Specificity ; Splenic Vein ; diagnostic imaging ; pathology ; Ultrasonography, Doppler, Color ; methods
2.The relationship between gene polymorphisms of integrin alpha-4 and intercellular adhesion molecule-1 and the risk of ulcerative colitis
Dingli ZHANG ; Xiaoxiao SHAO ; Dingyuan HU ; Hao WU ; Yi JIANG
Chinese Journal of Digestion 2023;43(12):820-827
Objective:To explore the relationship between gene polymorphisms of integral protein alpha-4 ( ITGA4) and intercellular adhesion molecule-1 ( ICAM-1) and the risk of ulcerative colitis (UC), and to analyze the effects of ITGA4 and ICAM-1 gene variations on the clinical response of vedolizumab (VDZ) treatment in UC patients at week-14. Methods:From January 1, 2010 to January 31, 2023, at Department of Gastroenterology of the Second Affiliated Hospital of Wenzhou Medical University, a total of 500 UC patients (UC group) and 529 gender- and age-matched healthy controls (healthy control group) were collected. The 500 UC patients were divided into mildly active stage (264 cases) and moderately to severely active stage (236 cases); distal colitis (299 cases), extensive colitis (201 cases); of the 500 UC patients, 120 cases received VDZ treatment, and 78 cases achieved clinical response and the remaining 42 cases had no response at week-14. Chi-square test and unconditional logistic regressionmodel were used to analyze the difference in gene polymorphisms of ITGA4 rs6740847, rs7562325 and ICAM-1 rs5498 gene polymorphisms between UC group and healthy control group, between patients of mildly active stage and patients of moderately to severely active stage, between patients with distal colitis and patients with extensive colitis, between patients with clinical response and patients without response through dominant, recessive, and allelic gene models. Results:The results of dominant gene model analysis showed that, the frequency of the variant allele G and the variant genotype AG+ GG of ITGA4 rs6740847 of UC group were lower than those of healthy control group (28.60% vs. 33.18%, 48.00%vs. 56.15%), the frequency of variant allele T and variant genotype CT+ TT of ITGA4 rs7562325 of UC group were higher than those of healthy control group (37.30% vs.31.57%, 62.20% vs. 54.63%), and the differences were statistically significant( χ2=5.04, 6.83, 7.49 and 6.06, P=0.025, 0.009, 0.006 and 0.014); the frequency of variant allele G and variant genotype AG+ GG of ITGA4 rs6740847 of patients with moderate to severe active UC were lower than those of patients with mild active UC (25.42% vs. 31.44%, 43.22% vs. 52.27%), while the frequency of variant allele T and variant genotype CT+ TT of ITGA4 rs7562325 were both higher than those of mild active UC (40.89% vs. 34.09%, 66.95% vs. 57.96%), and the differences were statistically significant( χ2=4.42, 4.09, 4.93 and 4.29, P=0.036, 0.043, 0.026 and 0.038); the frequency of variant allele G and variant genotype AG+ GG of ITGA4 rs6740847, the variant allele T of ITGA4 rs7562325, and the variant allele G and variant genotype AG+ GG of ICAM-1 rs5498 of patients with extensive colitis UC were lower than those of patients with distal colitis UC (24.38% vs. 31.44%, 39.80% vs. 53.51%, 33.58% vs.39.80%, 19.65% vs.26.09%, 35.82% vs. 45.82%), and the differences were statistically significant( χ2=5.87, 9.05, 3.97, 5.54 and 4.94, P=0.015, 0.003, 0.046, 0.019 and 0.026); the frequency of variant allele G and variant genotype AG+ GG of ITGA4 rs6740847 of patients with clinical response were higher than those of patients without response (34.62% vs.21.43%, 61.54% vs. 33.33%), and the differences were statistically significant( χ2=4.52 and 8.70, P=0.039 and 0.001). The results of recessive gene model analysis showed that, the frequency of variant genotype TT of ITGA4 rs7562325 of UC group was higher than that of healthy control group (12.40% vs.8.51%), and the difference was statistically significant ( χ2=4.18, P=0.041); the frequency of variant allele G and variant genotype GG of ICAM-1 rs5498 of patients with moderate to severe active UC were higher than those of patients with mild active UC (27.33% vs. 20.08%, 8.47% vs. 2.27%), and the differences were statistically significant( χ2=7.30 and 9.72, P=0.007 and 0.002); the frequency of variant allele T and variant genotype TT of ITGA4 rs7562325 of patients with clinical response were lower than those of patients without response (32.05% vs. 45.24%, 10.26% vs. 23.81%), and the differences were statistically significant( χ2=4.09 and 3.93, P=0.043 and 0.047). Conclusions:The variation of ITGA4 rs6740847 gene may reduce the risk and disease activity of UC, and may increase the clinical response to VDZ treatment in UC patients. However, the variation of ITGA4 rs7562325 gene may increase the risk and disease activity of UC, and may reduce the clinical response to VDZ treatment in UC patients. The variation of ICAM-1 rs5498 gene may worsen the disease activity of UC. In addition, the variations of ITGA4 rs6740847, rs7562325 and ICAM-1 rs5498 gene may all reduce the risk of extensive colitis.
3.Transcriptomic analysis of SR8278 improving lacrimal gland dysfunction in-duced by jet lag in mice
Shenzhen HUANG ; Di QI ; Xiaoting PEI ; Dingli LU ; Hongli SI ; Duliurui HUANG ; Wenxiao ZHANG ; Mengru BA ; Shuting XUAN ; Zhijie LI
Recent Advances in Ophthalmology 2024;44(4):264-269
Objective To investigate the role and mechanism of SR8278,a synthetic antagonist of nuclear receptor subfamily 1 group D member 1(NR1D1),in alleviating the structural and functional impairment of the extraorbital lacrimal glands induced by jet lag in mice.Methods Totally 36 healthy wild C57BL/6J mice aged 8-10 weeks were randomly divid-ed into 3 groups(normal group,jet-lag group,and jet-lag+SR8278 group)after adapting to a circadian rhythm chamber under the 12 h light/12 h dark(12 h/12 h LD)cycle for 2 weeks,with 12 mice in each group.Mice in the normal group were fed in a circadian rhythm chamber in a 12 h LD cycle,mice in the jet-lag group were fed in a 12 h/12 h LD cycle with an 8-hour advanced LD schedule,and mice in the jet lag+SR8278 group were fed in a 12 h/12 h LD cycle with an 8-hour advanced LD schedule and received 25 mg·kg-1 SR8278.At the end of 5 days of intervention,locomotor activity,core body temperature and tear secretion of mice in each group were collected,and the weight of lacrimal gland tissues and size of lacrimal gland cells were measured.Immunohistochemical methods were used for histological evaluation of the extraor-bital lacrimal glands in mice.Lacrimal ribonucleic acid(RNA)was extracted for high-throughput RNA-sequencing analysis containing NR1D1,and the obtained transcriptomic data were used for KEGG and GO functional enrichment analysis.Re-sults Compared with the normal group,the jet-lag group had higher daytime activity,lower nighttime activity,higher daytime core body temperature,and lower nighttime core body temperature,with statistically significant differences(all P<0.05).Compared with the jet-lag group,the jet-lag+SR8278 group had lower daytime activity,higher nighttime activi-ty,lower daytime core body temperature,and higher nighttime core body temperature,with statistically significant differ-ences(all P<0.05).Compared with the normal group,the jet-lag group showed a decrease in lacrimal gland weight and tear secretion and an increase in size of lacrimal gland cells,with statistical significance(all P<0.05);compared with the jet-lag group,the jet-lag+SR8278 group had an increase in lacrimal gland weight and tear secretion and a decrease in size of lacrimal gland cells,with statistical significance(all P<0.05).Compared with the normal group,the jet-lag group showed a higher expression of NR1D1 in the lacrimal gland at night;compared with the jet-lag group,the jet-lag+SR8278 group showed a lower expression of NR1 D1 in the lacrimal gland at night(both P<0.05).Bioinformatics analysis showed 947 significantly different genes in the jet-lag group and the jet-lag+SR8278 group,of which 43 are significantly upregulated genes,and 904 are significantly downregulated genes.The Notch signaling pathway has the most significant difference.Conclusion SR8278 effectively enhances the tear secretion function of jet-lagged mice by targeting NR1D1 inhibition.This process may be completed through the Notch signaling pathway.
4.Effects of Dual-antiplatelet Medication Time on Efficacy and Safety of Postoperative Complications after Transcatheter Aortic Valve Implantation :A Meta-analysis
Yuexin ZHU ; Yusi HUANG ; Huiting CHEN ; Lei ZHANG ; Yang LI ; Qingchun ZENG ; Dingli XU
China Pharmacy 2019;30(13):1847-1853
OBJECTIVE: To systematically evaluate the effects of dual-antiplatelet medication time on efficacy and safety of postoperative complications after transcatheter aortic valve implantation (TAVI), and to provide evidence-based reference for the formulation of antiplatelet therapy after TAVI. METHODS: Retrieved from Cochrane clinical controlled trial registration center, PubMed, Embase, Web of Science, Wanfang database and CJFD, during database establishment to Feb. 2019, RCTs and observational study about efficacy (all-cause mortality and incidence of stroke) and safety (the incidence of major bleeding events) the effects of dual-antiplatelet therapy for postoperative complications after TAVI at different time points were collected. After data extraction of clinical studies met inclusion criteria, quality evaluation with Cochrane bias risk evaluation tool 5.1.0 (for RCT) or Newcastle- Ottawa Scale (for observational study), Meta-analysis was conducted by using Rev Man 5.3 and Stata 14.0 statistical software. Meta-regression analysis was also conducted for outcome and different treatment duration. RESULTS: A total of 3 RCTs and 10 observational studies were included, involving 2 868 patients. The results of Meta-analysis showed that the incidence of all-cause mortality one month and 6 months after medication were 0.05 [95%CI (0.03, 0.07), P<0.001] and 0.07 [95%CI (0.05, 0.08), P<0.001]. The incidence of major bleeding events 1, 3 and 6 months after medication were 0.14 [95%CI (0.08,0.19), P<0.001], 0.11 [95%CI (0.03, 0.19), P=0.007] and 0.13 [95%CI (0.05, 0.22), P=0.002]. The incidence of stroke after one month after medication was 0.04 [95%CI (0.03, 0.05), P<0.001]. Results of Meta-regression analysis showed that the all-caused mortality [regression coefficient=0.005 7, 95%CI (-0.001 6, 0.013 0), P=0.116], major bleeding [regression coefficient=-0.000 5,95%CI(-0.022 4,0.021 4), P=0.959] or the incidence of stroke [regression coefficient=0.001 4, 95%CI (-0.003 8, 0.006 5), P=0.570] were not related to medication duration of dual-antiplatelet therapy. CONCLUSIONS: The prolongation of the medication time of the dual-antiplatelet therapy has no significant effect on the efficacy and safety of TAVI.
5.Meta-analysis of Efficacy and Safety of Single or Dual Antiplatelet Therapy for Short-term Complications after Transcatheter Aortic Valve Implantation
Yuexin ZHU ; Yusi HUANG ; Huiting CHEN ; Lei ZHANG ; Yang LI ; Ziyuan ZOU ; Qingchun ZENG ; Dingli XU
China Pharmacy 2019;30(9):1271-1278
OBJECTIVE: To systematically evaluate effectiveness and safety of single antiplatelet therapy (SAPT) versus dual antiplatelet therapy (DAPT) on short-term complications after transcatheter aortic valve implantation (TAVI), and to provide evidence-based reference for clinical treatment. METHODS: Retrieved from PubMed, Cochrane clinical controlled trials registry, Web of Science, CNKI, Wanfang database, CBM and Chinese Clinical Trial Registry, RCTs and observational studies about effectiveness (all-cause mortality, incidence of stroke and incidence of myocardial infarction 30 days after operation) and safety (the incidence of bleeding events at 30 days after operation) of SAPT versus DAPT on short-term complications of TAVI were collected during the date of database establishment to Jan. 2019. After data extraction of included studies and quality evaluation with Cochrane system evaluator manual 5.1.0 (for RCT) and the Newcastle-Ottawa Scale (NOS) (for observational studies), Meta-analysis was conducted by using Rev Man 5.3 statistical software. RESULTS: Totally 3 RCTs and 7 cohort studies were included, involving 3 188 patients. Results of Meta-analysis showed that the incidence of all-cause mortality 30 days after operation [OR=0.48, 95% CI (0.32, 0.73), P<0.001] and the incidence of bleeding events 30 days after operation [OR=0.43, 95%CI (0.30, 0.59), P<0.001] in SAPT group were significantly lower than DAPT group, with statistical significance. There was no statistical significance in the incidence of stroke 30 days after operation [OR=0.63, 95%CI (0.38, 1.06) , P=0.08] or the incidence of myocardial infarction 30 days after operation [OR=1.09, 95%CI (0.46, 2.59), P=0.85] between 2 groups. CONCLUSIONS: Compared with DAPT, SAPT can decrease the incidence of all-cause mortality 30 days after TAVI and the incidence of bleeding events 30 days after TAVI.